Table 6 Baseline characteristics of potentially relapsing patients
Authors, year of publication | Patient’s status | Age (years) | Sex | Probable origin of infection | Chemoprophylaxis | Parasitaemia (parasites/µl) |
|---|---|---|---|---|---|---|
Bottieau [28], 2005 | T | 17 | M | Ghana | Mefloquine | – |
T | 22 | M | Nigeria | Mefloquine | – | |
T | 14 | M | Uganda | None | – | |
Collins et al. [29], 2002 | I | – | – | NA | NA | 3780 |
I | – | – | NA | NA | 2220 | |
I | – | – | NA | NA | 8560 | |
I | – | – | NA | NA | 9810 | |
I | – | – | NA | NA | 5376 | |
Nathwani et al. [30], 1991 | T | 24 | M | Papua New Guinea | Chloroquine, pyrimethamine | – |
Chin et al. [31], 1971 | E | – | M | NA | NA | – |
E | – | M | NA | NA | – | |
E | – | M | NA | NA | – | |
E | – | M | NA | NA | – | |
E | – | M | NA | NA | – | |
Garnham et al. [32], 1955 | I | – | – | NA | NA | – |
I | – | – | NA | NA | – | |
Jeffery [33], 1954 | I | – | – | NA | NA | – |
I | – | – | NA | NA | – |